Patel Anish's Form 4 filing
Enliven Therapeutics, Inc. (ELVN) · filed Aug 11, 2025
- Accession no.
- 0001415889-25-021456
- Filed
- Aug 11, 2025
- Trade date
- Aug 7, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $121.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel AnishCIK 0001967163 | Officer (CHIEF OPERATING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Common Stock | SSaleDisposed | −6,262 | $18.20 | −$113,968.4 | 290,380 | Indirect | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −405 | $18.93 | −$7,666.65 | 289,975 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.